| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23ec872637dd23aee3ea8f3de7258301 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate |
2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41f6ad877ea48b946b84dd6b100b1287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fce62ad8a996dc7b604f6a58759d096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18729f1fca024e0c0622eca4cc74f1b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7ae8f4bfe6a1a741252c67bb2ad9802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d59e08d51003db18121da16de2cbae1 |
| publicationDate |
2016-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016317507-A1 |
| titleOfInvention |
Forms of rifaximin and uses thereof |
| abstract |
The present invention relates to Rifaximin amorphous forms, to their use in medicinal preparations and to therapeutic methods using them. |
| priorityDate |
2008-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |